Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups (NCT06090643)
Implementation Research to Reduce Colorectal Cancer Disparities
🩺 Plain-English Summary (8th-Grade Level)
This clinical trial implements research strategies to increase colorectal cancer (CRC) screening rates among low income and ethnic minority groups. CRC is the second most common cause of cancer mortality in the United States and disproportionately burdens low income and ethnic minority groups. Fecal immunochemical testing (FIT) is a test to check for blood in the stool. A brush is used to collect water drops from around the surface of a stool while it is still in the toilet bowl. The samples are then sent to a laboratory, where they are checked for a human blood protein. Blood in the stool may be a sign of colorectal cancer. Despite its potential for reducing CRC incidence and mortality, screening remains woefully underutilized. There is an unmet need for practical and effective programs to improve CRC screening rates. By implementing a culturally-tailored screening CRC program that supports providers and clinic staff to encourage eligible patients to complete FIT, researchers hope to reduce cancer disparities among low-income and ethnic groups and increase the CRC screening rate, which will help providers find CRC sooner, when it may be easier to treat.
Who can join: Review the eligibility criteria below.
Location: UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Age range: 50 Years to 75 Years
🧪 Interventions in This Study
- Best Practice (OTHER)
- Consultation (OTHER)
- Educational Intervention (OTHER)
- Electronic Health Record Review (OTHER)
- Fecal Immunochemical Test (OTHER)
- Feedback (BEHAVIORAL)
- Health Education (BEHAVIORAL)
- Support Education Activity (OTHER)
- Text Message-Based Navigation Intervention (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Colorectal Carcinoma
- Community Genetic Navigation Engagement Specialists to Increase Knowledge About Colorectal Cancer Genetics in Hispanic/Latino/a Communities — Los Angeles, California
- A Dietary Intervention (Soy Soft Pretzels) for Reducing Chronic Inflammation in Obese Individuals — Columbus, Ohio
- A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas — Los Angeles, California
- CoGENES Randomized Controlled Trial (RCT) — Los Angeles, California
- Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis — Chicago, Illinois
Explore by condition: All Colorectal Carcinoma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.